NCT05801835 2023-09-21A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for InjectionCSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Phase NA Unknown36 enrolled